Items where Author is "Andreotti, Felicita"
Number of items: 5.
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection. (2023)
Eliano P. Navarese,
Przemysław Podhajski,
Paul A. Gurbel,
Klaudyna Grzelakowska,
Eleonora Ruscio,
Udaya Tantry,
Przemysław Magielski,
Aldona Kubica,
Piotr Niezgoda,
Piotr Adamski,
Roman Junik,
Grzegorz Przybylski,
Marta Pilaczyńska-Cemel,
Manali Rupji,
Giuseppe Specchia,
Jarosław Pinkas,
Robert Gajda,
Diana A. Gorog,
Felicita Andreotti
and
Jacek Kubica
![]()
When a meta-analysis equals a single large-scale trial with meaningful follow-up. (2021)
Eliano P Navarese,
Dean Kereiakes,
Diana Gorog,
Alexandra Lansky
and
Felicita Andreotti
![]()
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? (2021)
Diana Gorog,
Eliano P Navarese
and
Felicita Andreotti
![]()
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: A systematic review and meta-analysis. (2021)
Eliano P Navarese,
Alexandra Lansky,
Dean Kereiakes,
Jacek Kubica,
Paul A Gurbel,
Diana Gorog,
Marco Valgimigli,
Nick Curzen,
David. E. Kandzari,
Marc Bonaca,
Marc Brouwer,
Julia M Umińska,
Milosz Jaguszewski,
Paolo Raggi,
Ron Waksman,
Martin B. Leon,
William Wijns
and
Felicita Andreotti
![]()
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention. (2021)
Bhatt Deepak,
Juan Carlos Kaski,
Sean Delaney,
Mirvat Alasnag,
Felicita Andreotti,
Dominick J. Angiolillo,
Albert Ferro,
Diana Gorog,
Alberto Lorenzatti,
Mamas A. Mamas,
John McNeil,
José C Nicolau,
Gabriel Philippe Steg,
Juan Tamargo,
Tan Doreen
and
Marco Valgimigli
![]()